# NIH Reporter #1R01FD008780-01

Intraperitoneal CAR T-cell therapy for peritoneal mesothelioma

**Recipient:** Sloan Kettering Institute for Cancer Research

**Award Amount:** $650,000.00
**Ceiling:** $650,000.00

**Awarded:** September 23, 2026

**Identifier:** 1R01FD008780-01

The award supports a clinical trial evaluating the safety, dose, and efficacy of intraperitoneal CAR T-cell therapy for malignant peritoneal mesothelioma.

### Description

Funding for a phase I clinical trial of autologous, intraperitoneally administered mesothelin-targeted CAR T cells with a PD1 dominant negative receptor strategy for patients with malignant peritoneal mesothelioma.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11443990)